Sir2 enzyme inhibitors (Johns Hopkins University)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameSir2 enzyme inhibitors (Johns Hopkins University)
Drug Alias Name2'-O-AADPR3'-O-AADPR3'-O-acetyl-ADP-ribose2'-O-acetyl-ADP-ribose
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent deacetylase sirtuin 1 inhibitors
TargetsNAD-dependent deacetylase sirtuin 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins Technology VenturesJohns Hopkins University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A